与常用诊断性放射性药物使用相关的不良反应综述
Review of Adverse Reactions Associated with the Use of Common Diagnostic Radiopharmaceuticals.
作者信息
Meher Bikash Ranjan, Agrawal Kanhaiyalal, Gnanasegaran Gopinath
机构信息
Department of Pharmacology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Department of Nuclear Medicine, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
出版信息
Indian J Nucl Med. 2021 Apr-Jun;36(2):163-167. doi: 10.4103/ijnm.ijnm_219_20. Epub 2021 Jun 21.
Abstract
Radiopharmaceuticals are used in the diagnosis and management of various diseases. There are several reports of adverse reactions related to the use of radiopharmaceuticals, though it is not as common as conventional drugs. Adverse reactions related to radiopharmaceuticals have been not widely reported and documented. In this review, we have tried to summarize the adverse reactions associated with some of the commonly used radiopharmaceuticals.
摘要
放射性药物用于各种疾病的诊断和治疗。虽然与使用放射性药物相关的不良反应不像传统药物那样常见，但已有多篇相关报道。与放射性药物相关的不良反应尚未得到广泛报道和记录。在本综述中，我们试图总结一些常用放射性药物相关的不良反应。
相似文献
1
Review of Adverse Reactions Associated with the Use of Common Diagnostic Radiopharmaceuticals.
Indian J Nucl Med. 2021 Apr-Jun;36(2):163-167. doi: 10.4103/ijnm.ijnm_219_20. Epub 2021 Jun 21.
2
Adverse reactions to radiopharmaceuticals in France: analysis of the national pharmacovigilance database.
Ann Pharmacother. 2015 Jan;49(1):39-47. doi: 10.1177/1060028014558153. Epub 2014 Nov 3.
3
Evaluation of Radiopharmaceutical Adverse Reaction Reports to the British Nuclear Medicine Society from 2007 to 2016.
J Nucl Med. 2017 Dec;58(12):2010-2012. doi: 10.2967/jnumed.117.194092. Epub 2017 May 18.
4
Adverse reactions to radiopharmaceuticals.
Farm Hosp. 2021 Mar 30;45(3):142-149. doi: 10.7399/fh.11669.
5
Undesirable events with radiopharmaceuticals.
Tohoku J Exp Med. 2009 Apr;217(4):251-7. doi: 10.1620/tjem.217.251.
6
Radiopharmaceuticals Adverse Events Management.
Curr Radiopharm. 2025;18(1):45-55. doi: 10.2174/0118744710284298240419115911.
7
Full report on a survey of adverse reactions to radiopharmaceuticals from 1975 to 2017 in Japan.
Ann Nucl Med. 2020 Apr;34(4):299-304. doi: 10.1007/s12149-020-01439-w. Epub 2020 Jan 27.
8
Adverse reactions to therapeutic radiopharmaceuticals.
Appl Radiat Isot. 2024 Dec;214:111527. doi: 10.1016/j.apradiso.2024.111527. Epub 2024 Sep 24.
9
Adverse Events of Diagnostic Radiopharmaceuticals: A Systematic Review.
Semin Nucl Med. 2019 Sep;49(5):382-410. doi: 10.1053/j.semnuclmed.2019.06.006.
10
Adverse reactions and drug interactions with radiopharmaceuticals.
Drug Saf. 1993 Apr;8(4):280-94. doi: 10.2165/00002018-199308040-00003.
引用本文的文献
1
Adverse events associated with the use of radiopharmaceuticals: A prospective study from a tertiary care institute.
Perspect Clin Res. 2025 Apr-Jun;16(2):87-91. doi: 10.4103/picr.picr_89_24. Epub 2024 Sep 10.
2
Adverse Reactions by Radiopharmaceuticals: Retrospective Analysis of the Portuguese National Pharmacovigilance System.
Ann Pharmacother. 2025 Oct;59(10):919-927. doi: 10.1177/10600280251316542. Epub 2025 Feb 23.
3
Pharmacovigilance of Radiopharmaceuticals: Challenges and Opportunities.
J Pharm Technol. 2024 Oct;40(5):257-259. doi: 10.1177/87551225241266172. Epub 2024 Jul 27.
4
Medication reconciliation enhances the accuracy of gastric emptying scintigraphy.
EJNMMI Radiopharm Chem. 2024 Sep 26;9(1):68. doi: 10.1186/s41181-024-00299-3.
5
Radionuclide Cisternography with [Cu]Cu-DOTA.
Pharmaceuticals (Basel). 2023 Sep 7;16(9):1269. doi: 10.3390/ph16091269.
6
A Multi-Criteria Decision Aid Tool for Radiopharmaceutical Selection in Tau PET Imaging.
Pharmaceutics. 2023 Apr 21;15(4):1304. doi: 10.3390/pharmaceutics15041304.
7
Alveolar Hemorrhage Following Positron Emission Tomography/Computed Tomography in 2 Separate Episodes 5 Months Apart.
Am J Case Rep. 2023 Feb 1;24:e938668. doi: 10.12659/AJCR.938668.
8
Aerosolised micro and nanoparticle: formulation and delivery method for lung imaging.
Clin Transl Imaging. 2023;11(1):33-50. doi: 10.1007/s40336-022-00527-3. Epub 2022 Sep 29.
本文引用的文献
1
Liver Steatosis Secondary to PRRT With 177Lu-DOTATATE: An Unknown Adverse Effect.
Clin Nucl Med. 2020 May;45(5):374-376. doi: 10.1097/RLU.0000000000002979.
2
Cutaneous reaction following technetium-99 m diphosphonate administration: an exceptional case.
J Eur Acad Dermatol Venereol. 2020 Mar;34(3):e135-e136. doi: 10.1111/jdv.16091. Epub 2019 Dec 5.
3
Adverse Events of Diagnostic Radiopharmaceuticals: A Systematic Review.
Semin Nucl Med. 2019 Sep;49(5):382-410. doi: 10.1053/j.semnuclmed.2019.06.006.
4
The Global Perspective of Pharmacovigilance in Nuclear Medicine Practice.
Indian J Nucl Med. 2018 Oct-Dec;33(4):269-272. doi: 10.4103/ijnm.IJNM_103_18.
5
Materiovigilance: An Indian perspective.
Perspect Clin Res. 2018 Oct-Dec;9(4):175-178. doi: 10.4103/picr.PICR_26_18.
6
Adverse Reactions to Radiopharmaceuticals: A Survey Based on Clinical Cases Using Criteria of Systematic Review.
Ther Innov Regul Sci. 2018 Jan;52(1):109-113. doi: 10.1177/2168479017716717. Epub 2017 Jun 30.
7
Evaluation of Radiopharmaceutical Adverse Reaction Reports to the British Nuclear Medicine Society from 2007 to 2016.
J Nucl Med. 2017 Dec;58(12):2010-2012. doi: 10.2967/jnumed.117.194092. Epub 2017 May 18.
8
Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors.
J Nucl Med. 2016 May;57(5):708-14. doi: 10.2967/jnumed.115.163865. Epub 2016 Jan 14.
9
A questionnaire based study to assess knowledge, attitude and practice of pharmacovigilance among undergraduate medical students in a Tertiary Care Teaching Hospital of South India.
Perspect Clin Res. 2015 Oct-Dec;6(4):217-21. doi: 10.4103/2229-3485.167102.
10
Adverse reactions to radiopharmaceuticals in France: analysis of the national pharmacovigilance database.
Ann Pharmacother. 2015 Jan;49(1):39-47. doi: 10.1177/1060028014558153. Epub 2014 Nov 3.
Zotero 插件